Table 3.
Selection of important emerging infectious diseases since 2003
| 2020 | SARS-CoV-2 |
| 2016 | Plasmid-mediated colistin resistance in Enterobacteriaceae (mcr-1) |
| 2015 | Zika virus |
| 2013 | Ebola virus in West Africa |
| Influenza virus A/H7N9 | |
| Candida auris invasive hospital-acquired infections | |
| 2012 | MERS-CoV |
| 2011 | Escherichia coli O104:H4 |
| 2010 | New Delhi metalloprotease-associated carbapenem resistance in Enterobacterales |
| Huaiyangshan virus, associated with severe fever and thrombocytopenia syndrome | |
| 2009 | Influenza virus A/H1N1pdm09 |
| 2008 | Artemisinin-resistant Plasmodium falciparum |
| Plasmodium knowlesi | |
| Lujo virus | |
| 2006 | Extensively drug-resistant Mycobacterium tuberculosis |
| 2005 | Human retroviruses HTLV-3 and HTLV-4 |
| 2004 | Re-emergence of influenza virus A/H5N1 |
| 2003 | SARS-CoV |